NVAX Novavax, Inc. Stock Quote

NVAX [NASD]

Index	-	P/E	-	EPS (ttm)	-9.25	Insider Own	0.20%	Shs Outstand	74.09M	Perf Week	-8.15%
Market Cap	14.80B	Forward P/E	5.50	EPS next Y	35.19	Insider Trans	-59.37%	Shs Float	73.34M	Perf Month	0.46%
Income	-615.10M	PEG	-	EPS next Q	-3.63	Inst Own	59.40%	Short Float	8.29%	Perf Quarter	-12.70%
Sales	919.50M	P/S	16.09	EPS this Y	-32.00%	Inst Trans	2.10%	Short Ratio	1.42	Perf Half Y	47.09%
Book/sh	14.23	P/B	13.59	EPS next Y	648.10%	ROA	-40.60%	Target Price	271.75	Perf Year	44.37%
Cash/sh	26.11	P/C	7.41	EPS next 5Y	0.00%	ROE	-125.70%	52W Range	76.59 - 331.68	Perf YTD	73.40%
Dividend	-	P/FCF	25.71	EPS past 5Y	9.50%	ROI	-38.00%	52W High	-41.70%	Beta	1.62
Dividend %	-	Quick Ratio	1.90	Sales past 5Y	67.30%	Gross Margin	-	52W Low	152.46%	ATR	14.81
Employees	791	Current Ratio	1.90	Sales Q/Q	13143.40%	Oper. Margin	-65.50%	RSI (14)	49.09	Volatility	9.18% 7.67%
Optionable	Yes	Debt/Eq	0.44	EPS Q/Q	-423.70%	Profit Margin	-66.90%	Rel Volume	0.62	Prev Close	203.24
Shortable	Yes	LT Debt/Eq	0.33	Earnings	Aug 05 AMC	Payout	-	Avg Volume	4.27M	Price	193.36
Recom	2.00	SMA20	-2.71%	SMA50	6.67%	SMA200	16.33%	Volume	2,661,672	Change	-4.86%

May-12-21

Downgrade

JP Morgan

Overweight → Neutral

$285 → $161

Dec-14-20

Initiated

Jefferies

Buy

$200

Aug-06-20

Reiterated

H.C. Wainwright

Buy

$132 → $290

Aug-05-20

Upgrade

JP Morgan

Neutral → Overweight

$275

Aug-05-20

Downgrade

Ladenburg Thalmann

Neutral → Sell

$105

Jul-16-20

Reiterated

H.C. Wainwright

Buy

$101 → $132

Jul-08-20

Downgrade

Ladenburg Thalmann

Buy → Neutral

$50 → $105

Jun-29-20

Reiterated

H.C. Wainwright

Buy

$50 → $101

Jun-29-20

Reiterated

B. Riley FBR

Buy

$74 → $106

Jun-05-20

Upgrade

JP Morgan

Underweight → Neutral

$46

May-28-20

Reiterated

B. Riley FBR

Buy

$53 → $61

May-12-20

Reiterated

H.C. Wainwright

Buy

$33 → $50

Apr-30-20

Reiterated

H.C. Wainwright

Buy

$24 → $33

Nov-27-19

Resumed

B. Riley FBR

Buy

$12

Aug-14-19

Reiterated

H.C. Wainwright

Buy

$10 → $17

Feb-28-19

Downgrade

Piper Jaffray

Overweight → Underweight

$4.50 → $0.25

Dec-18-18

Initiated

Ladenburg Thalmann

Buy

Dec-11-18

Initiated

Oppenheimer

Outperform

Nov-26-18

Upgrade

Piper Jaffray

Neutral → Overweight

Sep-21-18

Upgrade

JP Morgan

Underweight → Overweight

Jul-26-21 03:59PM	Doctor on COVID-19 vaccination: Too little too late, better late than never, if anything it all counts Yahoo Finance Video
05:55AM	Is It Too Late to Buy Novavax Stock? Motley Fool
Jul-25-21 06:06AM	It's Game Over for Dogecoin, but These Stocks Can Still Go to the Moon Motley Fool
05:52AM	3 Red-Hot Stocks That Are Still Dirt Cheap Motley Fool
Jul-24-21 06:19AM	Do Earnings Reports Matter for Biotech Stocks? Motley Fool
Jul-23-21 01:53PM	Doctor on the Olympics regarding COVID-19: There are a lot of concerns Yahoo Finance Video
06:02AM	Why BioNTech, Moderna, and Novavax Stocks Soared This Week Motley Fool
Jul-22-21 02:36PM	We havent seen the high consequence variants yet: Doctor Yahoo Finance Video
02:26PM	Is Novavax Stock A Buy Or Sell As It Trails Covid Vaccine Leaders Pfizer, Moderna? Investor's Business Daily
09:20AM	10 Best One Dollar Stocks to Buy Now Insider Monkey
Jul-21-21 01:43PM	Its very premature to talk about booster vaccines: Doctor Yahoo Finance Video
Jul-20-21 05:45PM	Novavax (NVAX) Stock Sinks As Market Gains: What You Should Know Zacks
02:51PM	Likelihood of reaching herd immunity at this point is fairly low: Epidemiologist Yahoo Finance Video
Jul-19-21 03:12PM	Why Coronavirus Stocks Are Zooming Higher Today Motley Fool +12.78%
02:01PM	Vaccination is really our route out of this pandemic: Doctor Yahoo Finance Video
12:29PM	Covid-19 Opportunity Still at Play for Novavax, Says Top Analyst TipRanks
Jul-16-21 02:46PM	Moderna surges, Square to enter DeFi space, Intel in talks to buy GlobalFoundries Yahoo Finance Video
01:37PM	We need to continue mask wearing even with vaccination: Doctor Yahoo Finance Video
06:00AM	3 Things About Novavax That Smart Investors Know Motley Fool
Jul-15-21 05:50PM	Novavax (NVAX) Gains As Market Dips: What You Should Know Zacks
02:58PM	Coronavirus vaccines are a miracle of science: Doctor Yahoo Finance Video
Jul-14-21 01:49PM	Pockets of the U.S. seeing potential for a 4th COVID-19 wave: Doctor Yahoo Finance Video
09:11AM	15 Best Penny Stocks to Buy Now Insider Monkey
06:10AM	Why Novavax Stock Soared 90% in the First Half of 2021 Motley Fool
Jul-13-21 05:06AM	COVID-19 Vaccines: How Much Revenue Will Each Drugmaker Generate in 2021? Motley Fool
Jul-12-21 03:09PM	If vaccinated you are very protected against all the variants that we have right now: Doctor Yahoo Finance Video
01:22PM	Is Novavax Stock A Buy On The Effectiveness Of Its Coronavirus Vaccine? Investor's Business Daily
Jul-11-21 06:06AM	These Stocks Will See Sales More Than Double in 2022, According to Wall Street Motley Fool
Jul-09-21 05:45PM	Novavax (NVAX) Stock Sinks As Market Gains: What You Should Know Zacks
02:22PM	Doctor: I would discourage getting booster shot different from the vaccine you received Yahoo Finance Video
05:55AM	Why Novavax Stock Dropped This Week Motley Fool
Jul-08-21 01:57PM	Doctor: If you are unvaccinated you are at risk Yahoo Finance Video
11:48AM	Why Moderna and Novavax Stocks Are Jumping Today Motley Fool
06:51AM	Vaccine Stocks Fall as Delta Becomes Dominant Variant in US Zacks
Jul-07-21 09:16PM	Why Novavax Was Up 44% in June Motley Fool -13.67%
04:06PM	Vaccine Stocks Moderna, Novavax Crumble Under Weight Of Delta Variant Investor's Business Daily
01:46PM	People will start to get sick and die again if we dont get vaccinated: Doctor Yahoo Finance Video
Jul-06-21 02:21PM	Doctor on COVID-19 recovery: We cant let down our guard Yahoo Finance Video
08:30AM	Novavax to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights on August 5, 2021 PR Newswire
Jul-02-21 05:45PM	Novavax (NVAX) Gains But Lags Market: What You Should Know Zacks
03:38PM	Why Johnson & Johnsons vaccine update is welcome news Yahoo Finance Video
01:39PM	Without global control of the pandemic were going to see new variants: Doctor Yahoo Finance Video
06:30AM	This is Novavax's Biggest Challenge Right Now Motley Fool
06:06AM	3 Value Stocks That'll Make You Richer in July (and Beyond) Motley Fool
06:00AM	Can Novavax Beat Moderna and Pfizer in Preventing Severe COVID? Motley Fool
02:36AM	UPDATE 2-Novavax says Taiwan has opted to get firm's COVID-19 vaccine via COVAX Reuters
Jul-01-21 09:03PM	Novavax says Taiwan has opted to get firm's COVID vaccine via COVAX Reuters
02:10PM	Delta variant of COVID-19 creates surges in Europe and Asia, as Euro 2020 soccer tournament sparks outbreak MarketWatch
10:00AM	How High Can Novavax's Shares Go? Motley Fool
09:04AM	Novavax's experimental COVID-19 shot has 86.4% efficacy against the Alpha variant MarketWatch
09:03AM	Vaccine Makers Stocks Are Moving as Also-Rans Fight for Spots in the Market Barrons.com
09:00AM	Here's What May Drive Novavax Shares Higher Motley Fool
08:30AM	This Is Novavax's Biggest Opportunity Right Now Motley Fool
07:29AM	Novavax COVID Vaccine Candidate Shows 86.3% Efficacy Vs. Alpha Variant TheStreet.com
06:05AM	How Big of a Splash Might Novavax Make in the COVID Vaccine Market? Motley Fool
Jun-30-21 05:50PM	Novavax (NVAX) Outpaces Stock Market Gains: What You Should Know Zacks
05:26PM	Novavax Publishes Results of United Kingdom Phase 3 Clinical Trial in New England Journal of Medicine, Demonstrating High Levels of Efficacy of COVID-19 Vaccine PR Newswire
02:39PM	Quidel CEO on the Delta variant impacting the need for COVID-19 testing Yahoo Finance Video
02:20PM	Going out without a mask is quite safe for those fully vaccinated: Doctor Yahoo Finance Video
01:42PM	15 Best Medical Stocks to Invest In Insider Monkey
12:21PM	Why Novavax Stock Is Rising Today Motley Fool
06:09AM	Is Novavax the Leader in Developing a Combo COVID/Flu Vaccine? Motley Fool
Jun-28-21 02:09PM	Delta variant is getting people in the public health world nervous: Doctor Yahoo Finance Video
09:05AM	Hedge Funds Have Never Been This Bullish On Novavax, Inc. (NVAX) Insider Monkey
08:06AM	The Covid-19 Booster Market Just Keeps Getting Bigger, Modernas CEO Says Barrons.com
Jun-27-21 05:51AM	These Are 5 of the Fastest-Growing Large-Cap Stocks on the Planet Motley Fool
Jun-26-21 06:03AM	Here's Why Novavax's Solid Vaccine Data Didn't Move the Stock Motley Fool
06:00AM	Is Novavax Stock a Buy? Motley Fool
12:00AM	Is Novavax's COVID-19 Vaccine Superior to the mRNA Vaccines? Motley Fool
Jun-25-21 06:00PM	Why Has Novavax Stock Been Jumping Higher? Motley Fool
03:18PM	Its concerning seeing variants popping up all over the world: Doctor Yahoo Finance Video
Jun-24-21 05:45PM	Novavax (NVAX) Gains But Lags Market: What You Should Know Zacks
05:04PM	Why COVID Vaccine Stocks Moderna, Novavax, and BioNTech Soared This Week Motley Fool
02:00PM	Unchecked spread in the U.S. is going to lead to other problems: Doctor Yahoo Finance Video
01:29PM	A Covid underclass is forming Yahoo Finance Video
Jun-23-21 05:50PM	Novavax (NVAX) Dips More Than Broader Markets: What You Should Know Zacks
01:48PM	Vaccination is very effective against the Delta variant: Doctor Yahoo Finance Video
Jun-22-21 06:38PM	Novavax Posted Great Vaccine Data. Heres Whats Next TipRanks +7.39%
05:52AM	Why Moderna Just Booked Another $3 Billion in Vaccine Orders and No One Cared Motley Fool
Jun-21-21 02:44PM	Delta COVID-19 variant likely to become dominant U.S. strain: Doctor Yahoo Finance Video
Jun-20-21 07:31AM	Is Now the Time to Go All-In On Novavax Stock? Motley Fool
Jun-19-21 07:00AM	A Biotech Pro Exited Novavax Stock. Here Are Three Stocks It Bought. Barrons.com
06:06AM	Got $10,000? Here Are Summer's Hottest Stocks to Buy Motley Fool
Jun-18-21 02:04PM	Gov. Duceys decision to block COVID-19 policies for universities is not based in science: Doctor Yahoo Finance Video
06:00AM	How Does Novavax Stack Up Against Today's Vaccine Leaders? Motley Fool
05:47AM	Why BioNTech, Moderna, and Novavax Stocks Sank This Week Motley Fool
Jun-17-21 04:02PM	Novavax to Participate in Fireside Chat at SVB Leerink CybeRx Series: Vaccine Forum PR Newswire
03:07PM	Affordable Care Act survives third Supreme Court challenge Yahoo Finance Video
10:28AM	2 Stocks That Are Running Circles Around Bitcoin This Year Motley Fool
10:19AM	Pfizer Covid-19 Vaccine Could See Blockbuster Sales for Years Barrons.com
09:22AM	Novavax to Participate in National Vaccine Advisory Committee Meeting PR Newswire
08:05AM	Dow Jones Futures Fall On Fed Rate-Hike Losses; Goldman In Buy Range, Covid Vaccine Play CureVac Crashes Investor's Business Daily
07:15AM	Raw Material Shortage Holding Up Novavax's COVID-19 Shot Manufacturing, Says Serum Institute Benzinga
06:00AM	Influencers with Andy Serwer: David Ricks Yahoo Finance Video
06:00AM	By next summer we'll have enough vaccines to vaccinate the world: Eli Lilly CEO Yahoo Finance Video
Jun-16-21 07:31PM	CureVac Started the Day Worth More Than Novavax. Then Its Vaccine News Hit. Barrons.com -5.79%
02:34PM	Biotech Stock Roundup: SAGE Declines on Data, Regulatory Updates From VRTX, ITOS Zacks
01:48PM	COVID-19 pandemic is far from over in other parts of the world: Doctor Yahoo Finance Video
10:20AM	Biogens FDA Win Marks a Mini-Rally in Biotech Stocks Barrons.com
09:57AM	FDA shifting the bar for approval with new Alzheimers drug: Eli Lilly CEO Yahoo Finance Video

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. In addition, the company develops vaccine candidates for the protection against middle east respiratory syndrome, as well as that is in preclinical work associated with severe acute respiratory syndrome; and ebola virus glycoprotein vaccine candidate, as well as COVID-19 vaccine for variant strain. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Glenn Gregory M	President, R&D	Jul 20	Sale	215.43	2,409	518,982	2,811	Jul 22 05:20 PM
Glenn Gregory M	President, R&D	Jul 15	Option Exercise	13.08	10,477	137,006	8,465	Jul 19 07:52 PM
Glenn Gregory M	President, R&D	Jul 15	Sale	179.45	5,654	1,014,597	2,811	Jul 19 07:52 PM
Erck Stanley C	President and CEO	Jul 02	Option Exercise	80.66	52,559	4,239,511	73,054	Jul 06 05:03 PM
Erck Stanley C	President and CEO	Jul 02	Sale	215.89	52,559	11,347,066	20,495	Jul 06 05:03 PM
Erck Stanley C	President and CEO	Jul 01	Option Exercise	61.59	52,620	3,240,965	73,115	Jul 06 05:03 PM
Erck Stanley C	President and CEO	Jul 01	Sale	212.88	52,620	11,201,513	20,495	Jul 06 05:03 PM
Glenn Gregory M	President, R&D	Jun 17	Sale	183.28	2,411	441,887	2,811	Jun 17 06:17 PM
Glenn Gregory M	President, R&D	Jun 15	Option Exercise	13.16	10,535	138,685	8,527	Jun 17 06:17 PM
Glenn Gregory M	President, R&D	Jun 15	Sale	191.42	5,716	1,094,130	2,811	Jun 17 06:17 PM
EVANS GARY C	Director	Jun 01	Sale	146.50	625	91,562	0	Jun 03 05:34 PM
Herrmann John A III	EVP, Chief Legal Officer	May 28	Option Exercise	14.83	2,895	42,932	3,170	Jun 02 04:59 PM
Herrmann John A III	EVP, Chief Legal Officer	May 28	Sale	149.14	2,895	431,748	275	Jun 02 04:59 PM
King Rachel K.	Director	May 19	Buy	139.64	700	97,748	2,800	May 21 05:06 PM
Glenn Gregory M	President, R&D	May 19	Sale	142.17	2,385	339,066	2,811	May 19 05:26 PM
Glenn Gregory M	President, R&D	May 17	Option Exercise	13.16	10,531	138,577	8,523	May 19 05:26 PM
Glenn Gregory M	President, R&D	May 17	Sale	133.98	5,712	765,267	2,811	May 19 05:26 PM
Trizzino John	EVP, CCO, CBO & Interim CFO	May 07	Sale	176.63	190	33,559	287	May 07 05:10 PM
Trizzino John	EVP, CCO, CBO & Interim CFO	May 05	Option Exercise	14.73	3,406	50,160	3,309	May 07 05:10 PM
Trizzino John	EVP, CCO, CBO & Interim CFO	May 05	Sale	185.46	3,022	560,471	287	May 07 05:10 PM
Herrmann John A III	EVP, Chief Legal Officer	Apr 30	Option Exercise	14.82	2,895	42,892	3,170	May 04 06:03 PM
Herrmann John A III	EVP, Chief Legal Officer	Apr 30	Sale	239.83	2,895	694,317	275	May 04 06:03 PM
Trizzino John	EVP, Chief Commercial Officer	Apr 07	Sale	178.03	191	34,004	287	Apr 07 05:09 PM
Trizzino John	EVP, Chief Commercial Officer	Apr 05	Option Exercise	34.01	3,404	115,771	3,308	Apr 07 05:09 PM
Trizzino John	EVP, Chief Commercial Officer	Apr 05	Sale	190.10	3,021	574,292	287	Apr 07 05:09 PM
Herrmann John A III	EVP, Chief Legal Officer	Mar 26	Option Exercise	14.82	2,894	42,886	3,169	Mar 30 06:10 PM
Herrmann John A III	EVP, Chief Legal Officer	Mar 26	Sale	186.80	2,894	540,609	275	Mar 30 06:10 PM
YOUNG JAMES F	Director	Mar 25	Option Exercise	8.96	47,500	425,438	57,500	Mar 25 06:41 PM
YOUNG JAMES F	Director	Mar 23	Option Exercise	46.00	10,000	460,000	20,000	Mar 25 06:41 PM
YOUNG JAMES F	Director	Mar 23	Sale	228.22	10,000	2,282,231	10,000	Mar 25 06:41 PM
MCMANUS MICHAEL A JR	Director	Mar 19	Sale	220.78	4,000	883,110	5,951	Mar 23 05:33 PM
Glenn Gregory M	President, R&D	Mar 17	Sale	218.86	2,423	530,304	2,811	Mar 17 06:35 PM
EVANS GARY C	Director	Mar 15	Option Exercise	19.52	24,500	478,330	40,599	Mar 17 06:36 PM
Glenn Gregory M	President, R&D	Mar 15	Option Exercise	109.95	10,531	1,157,843	8,523	Mar 17 06:35 PM
Glenn Gregory M	President, R&D	Mar 15	Sale	198.60	5,712	1,134,400	2,811	Mar 17 06:35 PM
EVANS GARY C	Director	Mar 15	Sale	211.21	24,500	5,174,536	16,099	Mar 17 06:36 PM
Trizzino John	EVP, Chief Commercial Officer	Mar 09	Sale	168.09	190	31,937	287	Mar 09 07:38 PM
Trizzino John	EVP, Chief Commercial Officer	Mar 05	Option Exercise	14.73	3,404	50,148	3,308	Mar 09 07:38 PM
Trizzino John	EVP, Chief Commercial Officer	Mar 05	Sale	163.46	3,021	493,824	287	Mar 09 07:38 PM
Herrmann John A III	EVP, Chief Legal Officer	Feb 26	Option Exercise	14.82	2,895	42,892	3,170	Mar 02 05:37 PM
Herrmann John A III	EVP, Chief Legal Officer	Feb 26	Sale	225.48	2,895	652,759	275	Mar 02 05:37 PM
Glenn Gregory M	President, R&D	Feb 18	Sale	269.57	2,434	656,134	2,811	Feb 18 06:59 PM
Glenn Gregory M	President, R&D	Feb 16	Option Exercise	13.16	10,531	138,577	8,523	Feb 18 06:55 PM
Glenn Gregory M	President, R&D	Feb 16	Sale	282.71	5,712	1,614,812	2,811	Feb 18 06:55 PM
Trizzino John	EVP, Chief Commercial Officer	Feb 09	Sale	324.50	194	62,953	287	Feb 09 07:40 PM
Trizzino John	EVP, Chief Commercial Officer	Feb 05	Option Exercise	14.73	3,406	50,160	3,309	Feb 09 07:40 PM
Trizzino John	EVP, Chief Commercial Officer	Feb 05	Sale	290.46	3,022	877,766	287	Feb 09 07:40 PM
Herrmann John A III	EVP, Chief Legal Officer	Feb 01	Option Exercise	18.15	15,022	272,724	15,297	Feb 03 05:37 PM
Herrmann John A III	EVP, Chief Legal Officer	Feb 01	Sale	241.50	15,022	3,627,789	275	Feb 03 05:37 PM
Trizzino John	EVP, CMO and CBO	Jan 07	Sale	124.17	506	62,830	287	Jan 07 07:08 PM
Trizzino John	EVP, CMO and CBO	Jan 05	Option Exercise	18.63	13,756	256,243	17,694	Jan 07 07:08 PM
Trizzino John	EVP, CMO and CBO	Jan 05	Sale	112.00	17,407	1,949,522	287	Jan 07 07:08 PM
YOUNG JAMES F	Director	Dec 31	Option Exercise	51.27	11,000	564,000	11,000	Jan 05 05:38 PM
DOUGLAS RICHARD	Director	Dec 31	Option Exercise	50.00	1,000	50,000	28,500	Jan 05 05:42 PM
YOUNG JAMES F	Director	Dec 31	Sale	113.09	11,000	1,244,014	0	Jan 05 05:38 PM
Erck Stanley C	President and CEO	Nov 16	Option Exercise	37.14	52,317	1,942,801	72,811	Nov 18 06:09 PM
Erck Stanley C	President and CEO	Nov 16	Sale	90.65	52,316	4,742,667	20,495	Nov 18 06:09 PM
Erck Stanley C	President and CEO	Oct 01	Sale	108.56	2	217	20,494	Oct 01 05:39 PM
Trizzino John	EVP, CBO and CFO	Sep 30	Sale	110.22	2,250	248,002	5,087	Oct 01 05:40 PM
Erck Stanley C	President and CEO	Sep 30	Sale	110.23	12,231	1,348,200	20,496	Oct 01 05:39 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 29	Sale	107.31	18,029	1,934,667	275	Sep 30 09:30 PM
Trizzino John	EVP, CBO and CFO	Sep 29	Sale	107.29	18,321	1,965,630	7,337	Sep 30 09:28 PM
Glenn Gregory M	President, R&D	Sep 29	Sale	107.02	19,949	2,134,844	1,561	Sep 30 09:29 PM
Erck Stanley C	President and CEO	Sep 29	Sale	107.80	4,112	443,267	32,727	Sep 30 09:27 PM
Trizzino John	EVP, CBO and CFO	Sep 28	Option Exercise	5.95	29,600	176,120	53,008	Sep 30 09:28 PM
Erck Stanley C	President and CEO	Sep 28	Option Exercise	5.95	50,000	297,500	74,606	Sep 30 09:27 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 28	Option Exercise	5.95	24,750	147,262	43,054	Sep 30 09:30 PM
Glenn Gregory M	President, R&D	Sep 28	Option Exercise	5.95	25,000	148,750	46,510	Sep 30 09:29 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 28	Sale	110.30	24,750	2,729,879	18,304	Sep 30 09:30 PM
Glenn Gregory M	President, R&D	Sep 28	Sale	110.30	25,000	2,757,456	21,510	Sep 30 09:29 PM
Trizzino John	EVP, CBO and CFO	Sep 28	Sale	110.30	25,000	2,757,456	25,658	Sep 30 09:28 PM
Erck Stanley C	President and CEO	Sep 28	Sale	110.30	25,000	2,757,456	36,839	Sep 30 09:27 PM
EVANS GARY C	Director	Aug 18	Option Exercise	31.02	10,500	325,700	332,479	Aug 20 06:09 PM
Glenn Gregory M	President, R&D	Aug 18	Option Exercise	33.56	55,921	1,876,525	57,760	Aug 20 06:14 PM
Herrmann John A III	EVP, Chief Legal Officer	Aug 18	Option Exercise	53.82	46,242	2,488,613	46,517	Aug 20 06:20 PM
MCMANUS MICHAEL A JR	Director	Aug 18	Option Exercise	27.60	8,000	220,800	17,951	Aug 20 06:22 PM
Trizzino John	EVP, CBO and CFO	Aug 18	Option Exercise	50.95	42,788	2,179,986	47,875	Aug 20 06:25 PM
Trizzino John	EVP, CBO and CFO	Aug 18	Sale	148.78	42,788	6,366,182	5,087	Aug 20 06:25 PM
MCMANUS MICHAEL A JR	Director	Aug 18	Sale	146.00	8,000	1,168,000	9,951	Aug 20 06:22 PM
Herrmann John A III	EVP, Chief Legal Officer	Aug 18	Sale	144.33	46,242	6,673,982	275	Aug 20 06:20 PM
Glenn Gregory M	President, R&D	Aug 18	Sale	145.20	55,921	8,119,860	1,839	Aug 20 06:14 PM
EVANS GARY C	Director	Aug 18	Sale	150.44	10,500	1,579,620	321,979	Aug 20 06:09 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience